SCHEMBL974381

SCHEMBL974381

O=C(NO)c1ccccc1OCc1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SGMS2 Q8NHU3 6/20 0.72
NPC1 O15118 1/20 0.68
GAA P10253 1/20 0.67
KMT2A Q03164 3/20 0.63
L3MBTL1 Q9Y468 2/20 0.63
MEN1 O00255 2/20 0.63
LMNA P02545 1/20 0.63
MAPT P10636 1/20 0.63
ALDH1A1 P00352 1/20 0.63
LIG1 P18858 1/20 0.60
TDP1 Q9NUW8 1/20 0.59
FAAH O00519 1/20 0.59
CNR1 P21554 1/20 0.59
CNR2 P34972 1/20 0.59
RAB9A P51151 1/20 0.57
PPIA P62937 1/20 0.56
HTT P42858 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6748166 0.87 SGMS2 (0.72) SGMS2NPC1GAAKMT2AL3MBTL1
SCHEMBL14428116 0.85 SGMS2 (0.75) SGMS2NPC1GAAKMT2AL3MBTL1
SCHEMBL19667131 0.85 LRRK2 (0.64) SGMS2NPC1GAAKMT2AL3MBTL1
SCHEMBL875474 0.84 SGMS2 (1.00) SGMS2NPC1GAAKMT2AL3MBTL1
SCHEMBL4147978 0.83 SGMS2 (0.67) SGMS2NPC1GAAKMT2AL3MBTL1
SCHEMBL4147984 0.83 SGMS2 (0.67) SGMS2NPC1GAAKMT2AL3MBTL1
SCHEMBL3018273 0.83 SGMS2 (0.76) SGMS2NPC1GAAKMT2AL3MBTL1
SCHEMBL112903 0.82 SGMS2 (0.66) SGMS2NPC1GAAKMT2AL3MBTL1
SCHEMBL29433417 0.82 SGMS2 (0.66) SGMS2NPC1GAAKMT2AL3MBTL1
SCHEMBL9696207 0.82 SGMS2 (0.66) SGMS2NPC1GAAKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8673911-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2014-03-18 US disclosed
US-8673911-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2014-03-18 US disclosed
US-8673911-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2014-03-18 US disclosed
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2014-02-13 US disclosed
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2014-02-13 US disclosed
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2014-02-13 US disclosed
WO-2013059582-A2 SMALL MOLECULE INHIBITORS OF HISTONE DEACTEYLASES NUPOTENTIAL, INC. (US) 2013-04-25 WO disclosed
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2011-01-27 US disclosed
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2011-01-27 US disclosed
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2011-01-27 US disclosed
WO-2009055917-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2009-05-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC11, HDAC3 SGMS2 2102/4885NPC1 1513/4885GAA 245/4885
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC11, HDAC3 SGMS2 2102/4885NPC1 1513/4885GAA 245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.